The store will not work correctly when cookies are disabled.
2-(5-(4-hydroxy-3-isopropylphenoxy)-4,6-dimethyl-2,3-dihydrobenzofuran-2-yl)acetic acid
ID: ALA248315
PubChem CID: 22228623
Max Phase: Preclinical
Molecular Formula: C21H24O5
Molecular Weight: 356.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2c(c(C)c1Oc1ccc(O)c(C(C)C)c1)CC(CC(=O)O)O2
Standard InChI: InChI=1S/C21H24O5/c1-11(2)16-8-14(5-6-18(16)22)26-21-12(3)7-19-17(13(21)4)9-15(25-19)10-20(23)24/h5-8,11,15,22H,9-10H2,1-4H3,(H,23,24)
Standard InChI Key: DYCBQLSLNKIBEX-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
-3.0389 -3.8166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0401 -4.6440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3253 -5.0569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6088 -4.6435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6117 -3.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3271 -3.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8988 -3.3978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1828 -3.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1830 -4.6303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5322 -5.0400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5245 -3.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7549 -5.0559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7535 -3.4043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7537 -2.5793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4679 -3.8170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0272 -3.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2403 -3.7955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2457 -4.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0369 -4.8748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5178 -4.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8969 -5.0438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3427 -4.1914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7617 -4.9020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5867 -4.8945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3558 -5.6202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5172 -2.5645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 12 1 0
6 1 1 0
1 13 1 0
1 2 2 0
13 14 1 0
5 7 1 0
13 15 1 0
17 18 1 0
3 4 2 0
7 8 1 0
8 9 2 0
4 5 1 0
16 17 1 0
18 19 1 0
19 20 1 0
20 16 1 0
9 10 1 0
9 21 1 0
10 18 2 0
20 22 1 0
2 3 1 0
22 23 1 0
17 11 2 0
23 24 2 0
11 8 1 0
23 25 1 0
5 6 2 0
11 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.42 | Molecular Weight (Monoisotopic): 356.1624 | AlogP: 4.70 | #Rotatable Bonds: 5 |
Polar Surface Area: 75.99 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.76 | CX Basic pKa: ┄ | CX LogP: 5.10 | CX LogD: 1.82 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.81 | Np Likeness Score: 0.69 |
References
1. Haning H, Mueller U, Schmidt G, Schmeck C, Voehringer V, Kretschmer A, Bischoff H.. (2007) Novel heterocyclic thyromimetics. Part 2., 17 (14): [PMID:17499989] [10.1016/j.bmcl.2007.04.085] |